The activation of certain molecular pathways including c-Jun NH2-terminal kinase, NF-κB, and p38-MAPK could aggravate the development of inflammation which displayed a strong relationship with insulin resistance, thus inducing DCM [36–38]. Here, NFKB1 is linked to familial dilated cardiomyopathy.